Literature DB >> 10195773

Immunoadjuvant action of plasmid DNA in liposomes.

M Gürsel1, S Tunca, M Ozkan, G Ozcengiz, G Alaeddinoglu.   

Abstract

Bacterial DNA and oligodeoxynucleotides containing immunostimulatory sequences with a CpG motif stimulated a Th1 type response in vivo. The adjuvant action of a non-coding plasmid DNA derived from pRc/CMV HBS (encoding the S region of hepatitis B surface antigen, HBsAg) in mice was investigated. The role of methylation on the adjuvanticity of the plasmid as well as the effect of vaccine formulation employed on the outcome of antigen-specific humoral and cellular responses were also studied. The results demonstrated that plasmid DNA acted as a Th1 promoting adjuvant when mixed as such or co-entrapped in liposomes with a very low dose of antigen. However, the adjuvant activity was lost when separate liposome entrapped formulations of both the antigen and the plasmid DNA were mixed, indicating a necessity for the antigen and the plasmid DNA to contact the same APC for optimal immune activation. A decreased adjuvanticity of plasmid DNA upon methylation with HpaII methyltransferase was also demonstrated. A mechanism that may help partially explain the reduction in adjuvanticity after modification of C residues is also discussed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10195773     DOI: 10.1016/s0264-410x(98)00383-1

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  8 in total

Review 1.  The role of CpG in DNA vaccines.

Authors:  M J McCluskie; R D Weeratna; H L Davis
Journal:  Springer Semin Immunopathol       Date:  2000

Review 2.  Liposome-nucleic acid immunotherapeutics.

Authors:  Steven Dow
Journal:  Expert Opin Drug Deliv       Date:  2008-01       Impact factor: 6.648

3.  Cationic liposomes extend the immunostimulatory effect of CpG oligodeoxynucleotide against Burkholderia pseudomallei infection in BALB/c mice.

Authors:  Apichaya Puangpetch; Robert Anderson; Yan Y Huang; Rasana W Sermswan; Wanpen Chaicumpa; Stitaya Sirisinha; Surasakdi Wongratanacheewin
Journal:  Clin Vaccine Immunol       Date:  2012-03-21

Review 4.  Pathogen-associated molecular patterns on biomaterials: a paradigm for engineering new vaccines.

Authors:  Stacey L Demento; Alyssa L Siefert; Arunima Bandyopadhyay; Fiona A Sharp; Tarek M Fahmy
Journal:  Trends Biotechnol       Date:  2011-04-02       Impact factor: 19.536

5.  TLR9-targeted biodegradable nanoparticles as immunization vectors protect against West Nile encephalitis.

Authors:  Stacey L Demento; Nathalie Bonafé; Weiguo Cui; Susan M Kaech; Michael J Caplan; Erol Fikrig; Michel Ledizet; Tarek M Fahmy
Journal:  J Immunol       Date:  2010-07-26       Impact factor: 5.422

Review 6.  Structure-dependent immunostimulatory effect of CpG oligodeoxynucleotides and their delivery system.

Authors:  Nobutaka Hanagata
Journal:  Int J Nanomedicine       Date:  2012-04-27

7.  Molecular adjuvant interleukin-33 enhances the antifertility effect of Lagurus lagurus zona pellucida 3 DNA vaccine administered by the mucosal route.

Authors:  Y X Tu; X P Li; Z Kadir; F C Zhang
Journal:  Braz J Med Biol Res       Date:  2013-12-10       Impact factor: 2.590

8.  Immunization against full-length protein and peptides from the Lutzomyia longipalpis sand fly salivary component maxadilan protects against Leishmania major infection in a murine model.

Authors:  William H Wheat; Erik N Arthun; John S Spencer; Daniel P Regan; Richard G Titus; Steven W Dow
Journal:  Vaccine       Date:  2017-10-24       Impact factor: 3.641

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.